Ezequiel Gonzalez, FNP

Ezequiel Gonzalez practices at Accelerated Urgent Care in Bakersfield, California.

Ezequiel Gonzalez's NPI, 1215456017, was assigned on September 12, 2017. Ezequiel Gonzalez holds California license 95007163.

Ezequiel Gonzalez's primary practice is Accelerated Urgent Care, at 2251 Mt Vernon Ave, Bakersfield, CA 93306 in Kern County. The practice phone is (661) 885-6060.

Ezequiel Gonzalez's primary practice is Accelerated Urgent Care in Bakersfield, California. Ezequiel Gonzalez is also affiliated with Adventist Health Tulare. The medical group on file is Accelerated Urgent Care. Dmand AI also links Ezequiel Gonzalez to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ezequiel Gonzalez practices. Vendor and product names are available with a free account.

Nurse practitioner is Ezequiel Gonzalez's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Ezequiel Gonzalez is licensed in California.

Dmand AI lists insomnia among the conditions Ezequiel Gonzalez treats.

CMS data shows 19 Medicare services from Ezequiel Gonzalez across 1 procedure code in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $1,687 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Ezequiel Gonzalez in 2024. 71% of them have high blood pressure, and 63% have high cholesterol. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ezequiel Gonzalez's median patient age at 30, with 60% women.

In 2024, Ezequiel Gonzalez wrote 556 Medicare Part D claims for 152 patients. 84% of them were for generic drugs. CMS names the drug for 229 of them, across 16 drugs with 11 or more claims each, at $30,188 in total drug cost.

Ezequiel Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Ezequiel Gonzalez from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $27.